Skip to main content
Genomictree Inc. logo

Genomictree Inc. — Investor Relations & Filings

Ticker · 228760 ISIN · KR7228760005 KO Professional, scientific and technical activities
Open in API
Filings indexed 237 across all filing types
Latest filing 2021-12-13 Regulatory Filings
Country KR South Korea
Listing KO 228760

About Genomictree Inc.

https://genomictree.com/eng/

Genomictree Inc. is a molecular diagnostics company that develops and commercializes products for the early detection and diagnosis of cancer. The company specializes in epigenomics, utilizing its proprietary genomic-scale discovery tools to identify DNA methylation biomarkers. Its flagship product line, EarlyTect®, offers non-invasive tests for the early screening of colorectal, lung, and bladder cancers. Additionally, Genomictree provides AccuraTect™, a companion diagnostic test for cancer. The company's mission is to improve patient quality of life and reduce medical costs through accessible and accurate early-stage cancer detection.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (주주명부폐쇄기간 또는 기준일 설정). It is a standard corporate disclosure filed with the exchange to inform shareholders of the upcoming record date for the Annual General Meeting. Since it is a regulatory announcement that does not fit into specific categories like dividend or share issuance, and is not the meeting material itself, it falls under the general regulatory filing category.
2021-12-13 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company Genomictree (주식회사 지노믹트리) covering the period from January 1, 2021, to September 30, 2021. It contains detailed corporate information, business descriptions, capital structure, and governance details, which are characteristic of a comprehensive interim financial report filed with the Korean financial authorities (Financial Services Commission/Korea Exchange). It is not an announcement or a certification, but the full report itself. 9M 2021
2021-11-12 Korean
전환가액의조정(제1회차 CB)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Genomictree regarding the adjustment of the conversion price for its 1st series Convertible Bonds (CB) due to a decline in market price. This type of disclosure, which details changes to capital structure instruments like convertible debt, falls under the 'Capital/Financing Update' category as it directly relates to the company's financing activities and capital structure adjustments.
2021-11-01 Korean
기타경영사항(특허권취득)(자율공시)(메틸화 DNA 다중 검출방법)
Regulatory Filings Classification · 100% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent ('메틸화 DNA 다중 검출방법') by the company Genomictree. It details the patent's content, acquisition date, and strategic utilization plan. Since this is a regulatory announcement regarding corporate business developments that does not fit into specific financial reporting or governance categories, it is classified as a general regulatory filing.
2021-10-28 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company Genomictree, covering the period from January 1, 2021, to June 30, 2021. It contains detailed company information, business descriptions, capital changes, and governance details, which are characteristic of a comprehensive interim financial report. It is not an announcement or a certification, but the full report itself. H1 2021
2021-08-13 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a third-party capital increase (share issuance) by the company Genomictree. It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2021-08-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.